Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of SGLT Inhibition on Diabetic Cardiomyopathy

NCT04200586 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04200586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04200586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of SGLT Inhibition on Diabetic Cardiomyopathy
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Unknown status
Start date
April 9, 2020
Completion date
September 30, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction, type2 diabetes